Biotech industry seeks 2-yr stay on price control

January 2008
Chemical Business;Jan2008, Vol. 22 Issue 1, p75
Trade Publication
The article reports on the recommendation of the biotechnology industry that biotech products manufactured in India should be given a two-year moratorium from price control under the Indian National Pharmaceutical Pricing Authority (NPPA). It states that the move will give enough time to scale-up production and streamline costs. Some of the other requests by the industry include the present provisions for a 150% weighted tax deduction until March 31, 2007 and the exemption of technological import from withholding tax for a period of up to 2010.


Related Articles

  • NPPA hauls up GSK for overcharging on pain relief pill.  // FRPT- Chemical Snapshot;4/13/2014, p13 

    The article reveals that aside from rejecting global drug manufacturer GlaxoSmithKline's (GSK) plea to exempts it analgesic 'Crocin Advance' from price control, India's National Pharmaceutical Pricing Authority (NPPA) will penalize the GSK Comsumer Healthcare for selling it a hundred percent...

  • Price caps on 400 essential medicines extended with affordability in mind.  // Eastern Eye;12/19/2014, Issue 1282, p16 

    The article reports on the extension of the price caps on 52 medicines by the Indian government as the National Pharmaceutical Pricing Authority (NPPA) plans to improve the affordability of medicines in the country.

  • NPPA fixes prices of 20 drugs, stents slightly costlier.  // FRPT- Chemical Snapshot;4/18/2017, p9 

    The article reports on an administration of several drugs under price control approaches by the National Pharmaceutical Pricing Authority; and issuance of review orders for prices of drugs by the Department of Pharmaceuticals (DoP).

  • REPORT OF THE SPECIAL COMMITTEE ON CARRYOVER BASIS. Hardee, David W. // Tax Lawyer;Summer79, Vol. 32 Issue 4, p942 

    Highlights the report of the Special Committee on Carryover Basis of the American Bar Association. Results of the passage of a moratorium on carryover basis; Nature of the unrealized appreciation at death problem; Determination of cost of basis of carryover basis assets in the estate.

  • Bills Would Seal State, Local Sales Tax Deduction, Internet Access Tax Ban. Jagoda, Naomi // Bondbuyer.com;1/13/2015, p33 

    The article reports on legislative bills including a bill that would make the moratorium on taxing Internet access permanent. introduced by Republican Bob Goodlatte and a bill that would make the deduction for state and local sales taxes permanent introduced by Senator Dean Heller.

  • Drug Manufacturers' Association seeks court intervention.  // Chemical Business;Mar1998, Vol. 12 Issue 3, p77 

    Reports on the lawsuit filed by the Bulk Drug Manufacturers Association against the India's Union Government and the National Pharmaceutical Pricing Authority over the arbitrary price-control policy. Accusation on the government's failure of adhering to its own price-control guidelines; Effort...

  • More drugs brought under price control.  // FRPT- Chemical Snapshot;10/ 4/2014, p19 

    The article reports on the placing of 43 essential medicines under price control by the National Pharmaceutical Pricing Authority (NPPA) in India as of 2014. Topics discussed include the pending resolution of the drug pricing issue, and the price revision of 20 medicines based on earlier price...

  • Drug firms urged to register for online database.  // FRPT- Chemical Snapshot;10/ 4/2014, p21 

    The article reports on the call of India's National Pharmaceutical Pricing Authority (NPPA) for the registration of all pharmaceutical firms under the Integrated Pharmaceutical Database Management System (IPDMS) as of 2014. Topics discussed include the aim of online filing of returns to monitor,...

  • Drug Price Control.  // Economic & Political Weekly;8/30/2014, Vol. 49 Issue 35, p5 

    The article discusses the release of price notifications for diabetes and cardiovascular medicines under paragraph 19 of the Drug Prices Control Order (DPCO) by the National Pharmaceutical Pricing Authority (NPPA) in India. The notifications were essential to cover more of the medicines'...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics